Skip to main content
Home
FULL MENU Close Menu
Home
Home

Mary Ann Moon

Article

Intentional weight loss protects against endometrial cancer

Author:
Mary Ann Moon
Publish date: February 6, 2017

Women who deliberately lost 5% or more of their body weight during a 3-year period reduced their long-term risk of endometrial cancer by nearly 30...

  • Read More

News

Antiandrogen therapy improves survival after biochemical recurrence of prostate cancer

Author:
Mary Ann Moon
Publish date: February 1, 2017

Adding antiandrogen treatment to salvage radiotherapy markedly improves long-term survival and disease-specific mortality, reduces the rate of...

  • Read More

News

Smaller, intrapericardial LVAD noninferior to HeartMate II

Author:
Mary Ann Moon
Publish date: February 1, 2017

A smaller, centrifugal-flow left ventricular assist device that lies entirely within the pericardial space was found noninferior to the HeartMate...

  • Read More

News

Refractory RA patients respond well to peficitinib in phase II study

Author:
Mary Ann Moon
Publish date: January 31, 2017

A 12-week course of daily oral peficitinib improved the severity of refractory rheumatoid arthritis in a manufacturer-sponsored phase II trial of...

  • Read More

Article

Residual disease burden is prognostic across breast cancer phenotypes

Author:
Mary Ann Moon
Publish date: January 30, 2017

The Residual Cancer Burden measure is prognostic of long-term survival across all three phenotypic subtypes of breast cancer.

  • Read More

News

Adding bevacizumab improves PFS in extensive SCLC

Author:
Mary Ann Moon
Publish date: January 30, 2017

Phase III study results show that combining bevacizumab with chemotherapy improves PFS in SCLC.

  • Read More

Article

Intermittent breaks from sunitinib feasible in metastatic RCC

Author:
Mary Ann Moon
Publish date: January 30, 2017

Intermittent breaks from sunitinib therapy are feasible and don’t appear to compromise the agent’s clinical efficacy against metastatic renal cell...

  • Read More

News

HAART may contribute to profound escalation in syphilis

Author:
Mary Ann Moon
Publish date: January 28, 2017

HAART may be contributing to the profound escalation in syphilis infections worldwide, perhaps by impairing immunity to <i>Treponema...

  • Read More

News

Asymptomatic carriage of carbapenem-resistant Enterobacteriaceae ‘considerable’

Author:
Mary Ann Moon
Publish date: January 28, 2017

Genetic analyses of bacterial isolates from four large U.S. hospitals “underscore the need for continued surveillance” of carbapenem-resistant...

  • Read More

News

Bezlotoxumab prevents recurrent C. difficile infection

Author:
Mary Ann Moon
Publish date: January 25, 2017

Adding bezlotoxumab to standard antibiotic treatment of primary or recurrent Clostridium difficile infection reduces recurrences by 38%,...

  • Read More

News

USPSTF punts on sleep apnea screening

Author:
Mary Ann Moon
Publish date: January 24, 2017

The U.S. Preventive Services Task Force neither supports nor rejects screening asymptomatic adults for obstructive sleep apnea in the primary care...

  • Read More

News

Continuous glucose monitoring benefits patients with type 1 diabetes

Author:
Mary Ann Moon
Publish date: January 24, 2017

A 6-month course of continuous glucose monitoring modestly reduced HbA1c levels in patients with type 1 diabetes who used multiple daily insulin...

  • Read More

News

Deferring RT for brain mets in EGFR-mutated NSCLC shortens survival

Author:
Mary Ann Moon
Publish date: January 23, 2017

Deferring radiotherapy to administer epidermal growth factor receptor tyrosine kinase inhibitors first doesn’t prolong overall survival, it...

  • Read More

News

Cardiac events after NSCLC radiotherapy occur early

Author:
Mary Ann Moon
Publish date: January 23, 2017

Cardiac events are “relatively common,” affecting 23% of patients, and occur earlier than previously thought following radiotherapy for non–small-...

  • Read More

Article

Risk tool bests CDC criteria for initiating PrEP

Author:
Mary Ann Moon
Publish date: January 19, 2017

A risk-assessment tool that incorporates behavioral data is more specific than are CDC criteria for initiating PrEP and would allow more targeted...

  • Read More

Pages

  • « first
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close